Cargando…

Impact of Modifying Abicipar Manufacturing Process in Patients with Neovascular Age-Related Macular Degeneration: MAPLE Study Results

PURPOSE: To evaluate the impact of modifying the abicipar pegol (abicipar) manufacturing process on the safety and treatment effect of abicipar in patients with neovascular age-related macular degeneration (nAMD). METHODS: A new process for manufacturing abicipar was developed to reduce host cell im...

Descripción completa

Detalles Bibliográficos
Autores principales:	Callanan, David, Khurana, Rahul N, Maturi, Raj K, Patel, Sunil, Wykoff, Charles C, Eichenbaum, David, Khanani, Arshad M, Hassan, Tarek, Badger, Hanh, Mehta, Shraddha, Le, Grace, Attar, Mayssa, Seal, Jennifer, Li, Xiao-Yan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2023
Materias:	Clinical Trial Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10184835/ https://www.ncbi.nlm.nih.gov/pubmed/37197577 http://dx.doi.org/10.2147/OPTH.S405994

Ejemplares similares

Double-Masked, Randomized, Phase 2 Evaluation of Abicipar Pegol (an Anti-VEGF DARPin Therapeutic) in Neovascular Age-Related Macular Degeneration
por: Callanan, David, et al.
Publicado: (2018)

OPTIMAL MANAGEMENT OF PIGMENT EPITHELIAL DETACHMENTS IN EYES WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
por: Khanani, Arshad M., et al.
Publicado: (2018)

Cooling Anesthesia for Intravitreal Injection: Results of the Prospective Open-Label, Dose-Ranging COOL-1 Trial
por: Chao, Daniel L, et al.
Publicado: (2021)

Effect of Anti‐VEGF Therapy on the Disease Progression of Neovascular Age‐Related Macular Degeneration: A Systematic Review and Model‐Based Meta‐Analysis
por: Luu, Kenneth T., et al.
Publicado: (2022)

Home Monitoring of Age-Related Macular Degeneration: Utility of the ForeseeHome Device for Detection of Neovascularization
por: Yu, Hannah J., et al.
Publicado: (2020)

RETINAL FLUID AND THICKNESS AS MEASURES OF DISEASE ACTIVITY IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
por: Kaiser, Peter K., et al.
Publicado: (2021)

RETINAL VASCULITIS OR VASCULAR OCCLUSION AFTER BROLUCIZUMAB FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: A Systematic Review of Real-World Evidence
por: Wykoff, Charles C., et al.
Publicado: (2023)

Clinical experience with fixed bimonthly aflibercept dosing in treatment-experienced patients with neovascular age-related macular degeneration
por: Khanani, Arshad M
Publicado: (2015)

Pharmacokinetics of the Port Delivery System with Ranibizumab in the Ladder Phase 2 Trial for Neovascular Age-Related Macular Degeneration
por: Wykoff, Charles C., et al.
Publicado: (2022)

Avacincaptad pegol for geographic atrophy secondary to age-related macular degeneration: 18-month findings from the GATHER1 trial
por: Patel, Sunil S., et al.
Publicado: (2023)

Correction: Avacincaptad pegol for geographic atrophy secondary to age-related macular degeneration: 18-month findings from the GATHER1 trial
por: Patel, Sunil S., et al.
Publicado: (2023)

IMPACT OF RETINAL FLUID-FREE MONTHS ON OUTCOMES IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: A Treatment Agnostic Analysis of the HAWK and HARRIER Studies
por: Eichenbaum, David, et al.
Publicado: (2023)

Phase 1 Dose-Escalation Study of Plasma Kallikrein Inhibitor THR-149 for the Treatment of Diabetic Macular Edema
por: Dugel, Pravin U., et al.
Publicado: (2021)

Emerging Therapies in Neovascular Age-Related Macular Degeneration in 2020
por: Samanta, Anindya, et al.
Publicado: (2020)

Safety Outcomes of Brolucizumab in Neovascular Age-Related Macular Degeneration: Results From the IRIS Registry and Komodo Healthcare Map
por: Khanani, Arshad M., et al.
Publicado: (2021)

New Therapies of Neovascular AMD beyond Anti-VEGF Injections
por: Gahn, Greggory M., et al.
Publicado: (2018)

Impact of Prophylactic Ranibizumab to Prevent Neovascular Age-Related Macular Degeneration on Eyes With Intermediate Age-Related Macular Degeneration
por: Chan, Clement K., et al.
Publicado: (2023)

Brolucizumab vs aflibercept and ranibizumab for neovascular age-related macular degeneration: a cost-effectiveness analysis
por: Yu, Justin S, et al.
Publicado: (2021)

Gains in the current understanding of managing neovascular AMD with brolucizumab
por: Bodaghi, Bahram, et al.
Publicado: (2023)

Combination of ranibizumab and indomethacin for neovascular age-related macular degeneration: randomized controlled trial
por: Russo, Andrea, et al.
Publicado: (2018)

Retrospective Study of Ellipsoid Zone Integrity Following Treatment with Intravitreal Ocriplasmin (OZONE Study)
por: Drenser, Kimberly A, et al.
Publicado: (2021)

The Maple handbook: Maple V release 4
por: Redfern, Darren
Publicado: (1996)

The Maple handbook: Maple V release 3
por: Redfern, Darren
Publicado: (1994)

Management of Neovascular Age-related Macular Degeneration: A Review on Landmark Randomized Controlled Trials
por: Agarwal, Aniruddha, et al.
Publicado: (2016)

Five-year outcomes of intravitreal drug therapy for neovascular age-related macular degeneration in eyes with baseline vision 20/60 or better
por: Khanani, Arshad M, et al.
Publicado: (2019)

Introduction to Maple
por: Heck, Andre
Publicado: (1993)

Maple animation
por: Putz, John F
Publicado: (2003)

Understanding Maple
por: Thompson, Ian
Publicado: (2016)

Maple by example
por: Abell, Martha L, et al.
Publicado: (2005)

Introduction to Maple
por: Heck, André
Publicado: (2003)

The Maple handbook
por: Redfern, Darren
Publicado: (1993)

Introduction to maple
por: Heck, André
Publicado: (1996)

TENAYA and LUCERNE: Rationale and Design for the Phase 3 Clinical Trials of Faricimab for Neovascular Age-Related Macular Degeneration
por: Khanani, Arshad M., et al.
Publicado: (2021)

Differential equations theory and applications: with Maple®
por: Betounes, David
Publicado: (2001)

Differential equations with maple : revised for Maple V Release 4
Publicado: (1997)

Applied abstract algebra with MAPLE and MATLAB: a MAPLE and MATLAB approach
por: Klima, Richard, et al.
Publicado: (2015)

Safety and Tolerability of Intravitreal Carotuximab (DE-122) in Patients With Persistent Exudative Age-Related Macular Degeneration: A Phase I Study
por: Gonzalez, Victor H., et al.
Publicado: (2021)

Optimizing Anti-VEGF Treatment Outcomes for Patients with Neovascular Age-Related Macular Degeneration
por: Wykoff, Charles C., et al.
Publicado: (2018)

Classical mechanics with Maple
por: Greene, Ronald L
Publicado: (1995)

Experimental mathematics with MAPLE
por: Vivaldi, Franco
Publicado: (2001)

Cannot write session to /tmp/vufind_sessions/sess_8ogfmo7mp8bj98t9gbpss7vuqe